Koers Acro Biomedical Co., Ltd. Other OTC
Aandelen
ACBM
US0048921052
Voedselverwerking
Omzet 2021 | 1,2 mln. 1,12 mln. | Omzet 2022 | 658K 614K | Marktkapitalisatie | 270 mln. 252 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -7 mln. -6,53 mln. | Nettowinst (verlies) 2022 | -15 mln. -13,99 mln. | EV/omzet 2021 | 233 x |
Nettoliquiditeiten 2021 | 24,08K 22,45K | Nettoschuld 2022 | 98,69K 92,04K | EV/omzet 2022 | 410 x |
K/w-verhouding 2021 |
-32,5
x | K/w-verhouding 2022 |
-17
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 50,03% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Pao Chi Chu
CEO | Chief Executive Officer | 70 | 30-01-17 |
Shi Ming Li
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jer Li Lin
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Pao Chi Chu
CEO | Chief Executive Officer | 70 | 30-01-17 |
Cheng Hsiang Kao
PRN | Corporate Officer/Principal | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,32% | 8,01 mld. | |
+1,64% | 7,36 mld. | |
+10,50% | 6,54 mld. | |
-6,69% | 3,73 mld. | |
-13,51% | 3,42 mld. | |
-10,10% | 1,24 mld. | |
+8,34% | 935 mln. | |
-41,81% | 886 mln. | |
-19,81% | 827 mln. |